Galderma Group AGXSWX:GALD -2.75%15 OCF Margin % is 22.85% as of Dec. 2025, which is 302% above its 10-year median of 5.68. GuruFocus rates XSWX:GALD with a GF Score™ of 15/100. The stock has 4 warning signs investors should review. Among 959 Drug Manufacturers companies, Galderma Group AG ranks better than 82.38% on this metric.
The historical rank and industry rank for Galderma Group AG's OCF Margin % or its related term are showing as below:
XSWX:GALD'
s OCF Margin % Range Over the Past 10 Years
Min: 2.91 Med: 5.68 Max: 22.61
Current: 22.61
During the past 5 years, the highest OCF Margin % of Galderma Group AG was 22.61%. The lowest was 2.91%. And the median was 5.68%.
XSWX:GALD's OCF Margin % is ranked better than 82.38% of 959
companies
in the Drug Manufacturers industry
Industry Median: 9.94
vs XSWX:GALD: 22.61
Galderma Group AG OCF Margin % Related Terms
Galderma Group AG OCF Margin % Historical Data
* Premium members only.
The historical data trend for Galderma Group AG's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:GALD vs ZTS, UTHR, VTRS: OCF Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Galderma Group AG's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Galderma Group AG OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Galderma Group AG's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Galderma Group AG's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Galderma Group AG (XSWX:GALD) has a OCF Margin % of 22.85% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Galderma Group AG and its competitors. This is 302% above median its historical median of 5.68. Over the past decade, Galderma Group AG's OCF Margin % has ranged from 2.91 to 22.61. According to the industry distribution chart, Galderma Group AG ranks #169 out of 959 companies in the Drug Manufacturers industry, placing it in the top 17.6%.
Is Galderma Group AG's OCF Margin % too high?
Galderma Group AG's current OCF Margin % of 22.85% is 302% above median its 10-year median of 5.68. Over the past 10 years, this metric has ranged from a low of 2.91 to a high of 22.61. The Drug Manufacturers industry median OCF Margin % is 9.94. Galderma Group AG's value of 22.85% is 129.9% above this industry median. Based on the distribution chart, Galderma Group AG ranks #169 out of 959 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Galderma Group AG has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Galderma Group AG's OCF Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Galderma Group AG ranks #169 out of 959 companies for OCF Margin %. This places Galderma Group AG in the top 18% of its industry — outperforming the majority of peers. The industry median OCF Margin % is 9.94. Galderma Group AG's value of 22.85% is 129.9% above this benchmark. Historically, Galderma Group AG's own OCF Margin % has ranged from 2.91 to 22.61 over the past decade. While the company's 10-year median is 5.68 vs. the industry median of 9.94, Galderma Group AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 9.94, based on 959 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Galderma Group AG's current OCF Margin % of 22.85% is 129.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Galderma Group AG and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 9.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Galderma Group AG's current OCF Margin % is 22.85%, which is 302% above median its own 10-year median of 5.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Galderma Group AG stock overvalued right now?
Galderma Group AG (XSWX:GALD) has a current OCF Margin % of 22.85%. The current OCF Margin % is 22.85%, which is 302% above median its 10-year median of 5.68 and 129.9% above the Drug Manufacturers industry median of 9.94. Galderma Group AG's overall GF Score™ is 15/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Galderma Group AG (XSWX:GALD), the current OCF Margin % is 22.85% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a stand-alone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 40% of net sales from the US and employs more than 7,500 people.
15GF Score
Get the complete analysis for XSWX:GALD
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:GALD has been successfully added to your 